Bausch Health Companies advertising spend, FY2025
Bausch Health Companies (BHC) reported $766M of advertising expense for the fiscal year ended Dec 31, 2025. That is 7.5% of revenue of $10.3B. Down 2.5% from FY2024. Formerly Valeant Pharmaceuticals International and Biovail.
Key facts
- Ad spend is 1.2x its FY2015 level ($652M), faster than revenue (1.0x).
- The highest year on file is FY2024 at $786M; FY2025 is 3% below it.
- Largest increase +255.5% in FY2011; largest cut -18.1% in FY2017.
- Ad spend is 7.5% of revenue, up from 5.6% in FY2020.
- Bausch Health Companies spends more on advertising than 80% of the 458 US-listed companies tracked. Its ad-to-revenue ratio is 1.6x the median of 4.5%.
Ad spend by fiscal year
Ad spend as % of revenue
Ad spend in context, FY2025
Advertising was 22.3% of selling, general and administrative expense. Advertising was 1.2x research and development spending. Advertising equalled 42.3% of operating income.
| Advertising | $766M | AdvertisingExpense |
|---|---|---|
| Selling, general and administrative | $3.4B | ad spend = 22.3% |
| Research and development | $629M | ad spend = 1.2x R&D |
| Operating income | $1.8B | ad spend = 42.3% |
| Net income | $157M |
Same fiscal year and filing as the ad spend. Selling and marketing and SG&A usually include advertising.
History
Download CSV| Fiscal year | Period end | Ad spend | YoY | Revenue | Ad / revenue | Tag | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | $766M | -2.5% | $10.3B | 7.5% | AdvertisingExpense | 10-K Feb 19, 2026 |
| FY2024 | Dec 31, 2024 | $786M | +25.8% | $9.6B | 8.2% | AdvertisingExpense | 10-K Feb 19, 2026 |
| FY2023 | Dec 31, 2023 | $625M | +20.7% | $8.8B | 7.1% | AdvertisingExpense | 10-K Feb 19, 2026 |
| FY2022 | Dec 31, 2022 | $518M | +0.6% | $8.1B | 6.4% | AdvertisingExpense | 10-K Feb 20, 2025 |
| FY2021 | Dec 31, 2021 | $515M | +14.2% | $8.4B | 6.1% | AdvertisingExpense | 10-K Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $451M | -17.1% | $8B | 5.6% | AdvertisingExpense | 10-K Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | $544M | +13.1% | $8.6B | 6.3% | AdvertisingExpense | 10-K Feb 23, 2022 |
| FY2018 | Dec 31, 2018 | $481M | +4.1% | $8.4B | 5.7% | AdvertisingExpense | 10-K Feb 24, 2021 |
| FY2017 | Dec 31, 2017 | $462M | -18.1% | $8.7B | 5.3% | AdvertisingExpense | 10-K Feb 19, 2020 |
| FY2016 | Dec 31, 2016 | $564M | -13.5% | $9.7B | 5.8% | AdvertisingExpense | 10-K Feb 20, 2019 |
| FY2015 | Dec 31, 2015 | $652M | +49.9% | $10.4B | 6.2% | AdvertisingExpense | 10-K Feb 28, 2018 |
| FY2014 | Dec 31, 2014 | $435M | +57.0% | $8.2B | 5.3% | AdvertisingExpense | 10-K Mar 1, 2017 |
| FY2013 | Dec 31, 2013 | $277M | +75.8% | $5.8B | 4.8% | AdvertisingExpense | 10-K Apr 29, 2016 |
| FY2012 | Dec 31, 2012 | $158M | +48.3% | $3.5B | 4.5% | AdvertisingExpense | 10-K Feb 25, 2015 |
| FY2011 | Dec 31, 2011 | $106M | +255.5% | $2.4B | 4.4% | AdvertisingExpense | 10-K Feb 28, 2014 |
| FY2010 | Dec 31, 2010 | $29.9M | +199.0% | $1.2B | 2.5% | AdvertisingExpense | 10-K Feb 28, 2013 |
| FY2009 | Dec 31, 2009 | $10M | n/a | $820M | 1.2% | AdvertisingExpense | 10-K Feb 29, 2012 |
Ad spend, revenue and the ratio come from the linked filing. YoY compares each year with the fiscal year directly before it, under the same tag. A gap, a change of tag or a change of fiscal year end leaves it blank.
What the figure is
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Compared with similar spenders
The 6 companies closest to Bausch Health Companies in latest-year ad spend.
| Rank | Company | Ad spend | Ad / revenue | YoY | Fiscal year |
|---|---|---|---|---|---|
| 89 | Gap | $778M | 5.1% | -0.3% | FY2026 |
| 90 | EchoStar | $775M | 5.2% | +4.0% | FY2025 |
| 91 | LendingTree | $771M | 69.0% | +29.3% | FY2025 |
| 92 | Clorox | $770M | 10.8% | -7.5% | FY2025 |
| 93 | Bausch Health Companies | $766M | 7.5% | -2.5% | FY2025 |
| 94 | Playtika | $761M | 27.6% | +34.9% | FY2025 |
| 95 | Shopify | $753M | 6.5% | +37.9% | FY2025 |
Full ranking of 458 companies · Biggest cuts #103 · More on ads than R&D #84
Questions
How much does Bausch Health Companies spend on advertising?
Bausch Health Companies spent $766M on advertising in fiscal 2025, the year ended Dec 31, 2025, according to its 10-K filed Feb 19, 2026.
What percentage of revenue does Bausch Health Companies spend on advertising?
7.5% of revenue in fiscal 2025 ($766M against $10.3B). The median across the 458 companies tracked is 4.5%.
Is Bausch Health Companies spending more on advertising?
No. Ad spend fell 2.5% in fiscal 2025 from fiscal 2024.
How does Bausch Health Companies rank by advertising spend?
#93 of 458 US-listed companies with $50M or more in ad spend, ranked on each company's latest fiscal year.
Does Bausch Health Companies spend more on advertising than on R&D?
Yes. In fiscal 2025 it spent $766M on advertising and $629M on research and development.
What does Bausch Health Companies's advertising figure include?
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Company and source
- Filing
- 10-K for FY2025, filed Feb 19, 2026
- Accession number
0000885590-26-000023- Company
- Bausch Health Companies Inc., CIK 885590, SIC 2834 (Pharmaceutical Preparations)
- Former names
- Valeant Pharmaceuticals International, Biovail, Biovail Corp International, Biovail Corporation International
- Headquarters
- Quebec, A8
- Incorporated in
- NJ
- Fiscal year ends
- December 31
- Listed on
- NYSE
- SEC filer status
- Large accelerated filer
- Data
- SEC EDGAR XBRL company facts, retrieved Nov 18, 2026. Methodology.
- Cite
- Bausch Health Companies advertising spend, FY2009-FY2025. Aleksei Trudov, io.trudov.com, from SEC EDGAR XBRL company facts (latest: 10-K filed Feb 19, 2026), retrieved Nov 18, 2026. https://io.trudov.com/company/bausch-health-companies/advertising-spend/
- Download
- CSV, all years · CSV, all 458 companies